[go: up one dir, main page]

DE122005000049I2 - Neue Salzform von Pantoprazol - Google Patents

Neue Salzform von Pantoprazol

Info

Publication number
DE122005000049I2
DE122005000049I2 DE1999601840 DE69901840C DE122005000049I2 DE 122005000049 I2 DE122005000049 I2 DE 122005000049I2 DE 1999601840 DE1999601840 DE 1999601840 DE 69901840 C DE69901840 C DE 69901840C DE 122005000049 I2 DE122005000049 I2 DE 122005000049I2
Authority
DE
Germany
Prior art keywords
pantoprazole
salt form
new salt
new
dihydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE1999601840
Other languages
English (en)
Other versions
DE69901840D1 (de
DE69901840T2 (de
DE122005000049I1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Altana Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7881823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE122005000049(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma AG filed Critical Altana Pharma AG
Publication of DE122005000049I1 publication Critical patent/DE122005000049I1/de
Publication of DE122005000049I2 publication Critical patent/DE122005000049I2/de
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Drying Of Gases (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
DE1999601840 1998-08-18 1999-08-12 Neue Salzform von Pantoprazol Active DE122005000049I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19843413A DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
PCT/EP1999/005928 WO2000010995A1 (en) 1998-08-18 1999-08-12 Novel salt form of pantoprazole

Publications (2)

Publication Number Publication Date
DE122005000049I1 DE122005000049I1 (de) 2006-12-28
DE122005000049I2 true DE122005000049I2 (de) 2007-03-29

Family

ID=7881823

Family Applications (3)

Application Number Title Priority Date Filing Date
DE19843413A Expired - Fee Related DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
DE69901840T Expired - Lifetime DE69901840T2 (de) 1998-08-18 1999-08-12 Neue salzform von pantoprazol
DE1999601840 Active DE122005000049I2 (de) 1998-08-18 1999-08-12 Neue Salzform von Pantoprazol

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE19843413A Expired - Fee Related DE19843413C1 (de) 1998-08-18 1998-08-18 Neue Salzform von Pantoprazol
DE69901840T Expired - Lifetime DE69901840T2 (de) 1998-08-18 1999-08-12 Neue salzform von pantoprazol

Country Status (32)

Country Link
US (2) US6410569B1 (de)
EP (1) EP1105386B1 (de)
JP (1) JP2002523411A (de)
KR (1) KR100657835B1 (de)
CN (1) CN1146558C (de)
AT (1) ATE219074T1 (de)
AU (1) AU761715B2 (de)
BG (1) BG65255B1 (de)
BR (1) BR9914288A (de)
CA (1) CA2341031C (de)
CZ (1) CZ293734B6 (de)
DE (3) DE19843413C1 (de)
DK (1) DK1105386T3 (de)
EA (1) EA004431B1 (de)
EE (1) EE04278B1 (de)
ES (1) ES2178896T3 (de)
HR (1) HRP20010117B1 (de)
HU (1) HU226618B1 (de)
IL (3) IL141328A0 (de)
ME (1) ME00562B (de)
MX (1) MXPA01001758A (de)
NO (1) NO319782B1 (de)
NZ (1) NZ509761A (de)
PL (1) PL198801B1 (de)
PT (1) PT1105386E (de)
RS (1) RS50071B (de)
SI (1) SI1105386T1 (de)
SK (1) SK285105B6 (de)
TR (1) TR200100287T2 (de)
UA (1) UA58605C2 (de)
WO (1) WO2000010995A1 (de)
ZA (1) ZA200100934B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol
MY137726A (en) 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
TW200410955A (en) 2002-07-29 2004-07-01 Altana Pharma Ag Novel salt of (S)-PANTOPRAZOLE
DE10234617B4 (de) * 2002-07-29 2013-04-04 Nycomed Gmbh Neues Salz von (S)-Pantoprazol
EP1572680A2 (de) 2002-12-19 2005-09-14 Eva Pharmaceutical Industries Ltd. Festkörper pantoprazol natrium,bekannte pantoprazol natrium hydraten, verfahren zu deren herstellungen.
AU2004237362A1 (en) * 2003-05-06 2004-11-18 Altana Pharma Ag Proton pump inhibitors for the treatment of lower abdominal disorders
CL2004000983A1 (es) * 2003-05-08 2005-03-04 Altana Pharma Ag Composicion farmaceutica oral en forma de tableta que comprende a pantoprazol magnetico dihidratado, en donde la forma de tableta esta compuesto por un nucleo, una capa intermedia y una capa exterior; y uso de la composicion farmaceutica en ulceras y
PE20050150A1 (es) * 2003-05-08 2005-03-22 Altana Pharma Ag Una forma de dosificacion que contiene (s)-pantoprazol como ingrediente activo
WO2004100949A2 (en) * 2003-05-19 2004-11-25 Pliva-Istrazivanje I Razvoj D.O.O. Solid-state forms of 5-(difluoromethoxy)-2-((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole (pantoprazole) sodium aqua complexes
MXPA05013316A (es) * 2003-06-10 2006-03-17 Teva Pharma Proceso para preparar bencimidazoles 2[-(piridinil)metil]sulfinil-sustituidos y derivados clorados novedosos de pantoprazol.
WO2005012289A1 (en) * 2003-07-17 2005-02-10 Altana Pharma Ag Novel salt of (r) - pantoprazole
JP2006528158A (ja) * 2003-07-23 2006-12-14 アルタナ ファルマ アクチエンゲゼルシャフト プロトンポンプ阻害剤のアルカリ塩
CN100457104C (zh) * 2003-07-23 2009-02-04 尼科梅德有限责任公司 质子泵抑制剂的碱性盐
WO2005074932A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag The use of (s) - pantoprazole magnesium for the treatment of airway disorders
CA2554260A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Calcium, potassium, zinc, lithium and aluminium salts of pantoprazole and (s)-pantoprazole
WO2005074930A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations of (s) -pantoprazole with nsaid or corticosteroids
WO2005074898A2 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Composition comprising (s) pantoprazole and an antibiotic for treating helicobacter pylori
WO2005074931A1 (en) * 2004-01-28 2005-08-18 Altana Pharma Ag Pharmaceutical combinations comprising (s) -pantoprazole
EP1716136A1 (de) * 2004-02-11 2006-11-02 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridin benzimidazol sulfoxide hoher reinheit
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
ES2376466T3 (es) * 2004-05-07 2012-03-14 Nycomed Gmbh Forma de dosificación farmacéutica que comprende peletes, as�? como su procedimiento de fabricación.
WO2007041790A1 (en) * 2005-10-14 2007-04-19 Jon Pty Limited Salts of proton pump inhibitors and process for preparing same
US20080139623A1 (en) 2006-06-12 2008-06-12 Lilach Hedvati Amorphous and crystalline forms of pantoprazole magnesium salt
US20080177076A1 (en) * 2006-11-06 2008-07-24 Lilach Hedvanti Processes for preparing substantially pure pantoprazole magnesium
WO2017114898A1 (en) * 2015-12-30 2017-07-06 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of pantoprazole sodium sesquihydrate
EP3187494A1 (de) * 2015-12-30 2017-07-05 KRKA, tovarna zdravil, d.d., Novo mesto Verfahren zur herstellung von pantoprazole natrium sesquihydrat

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) * 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
DE4018642C2 (de) * 1990-06-11 1993-11-25 Byk Gulden Lomberg Chem Fab Neue Salzform des 5-Difluormethoxy-2-[(3,4-dimethoxy-2-pyridyl) methylsulfinyl]-1H-benzimitazol-Natriumsalzes
YU48263B (sh) * 1991-06-17 1997-09-30 Byk Gulden Lomberg Chemische Fabrik Gmbh. Postupak za dobijanje farmaceutskog preparata na bazi pantoprazola
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
DE19843413C1 (de) * 1998-08-18 2000-03-30 Byk Gulden Lomberg Chem Fab Neue Salzform von Pantoprazol

Also Published As

Publication number Publication date
TR200100287T2 (tr) 2001-07-23
NO20010718L (no) 2001-02-12
CZ293734B6 (cs) 2004-07-14
EE04278B1 (et) 2004-04-15
RS50071B (sr) 2009-01-22
ME00562A (en) 2011-12-20
DE69901840D1 (de) 2002-07-18
JP2002523411A (ja) 2002-07-30
HRP20010117B1 (en) 2010-07-31
BG105173A (en) 2001-11-30
EP1105386B1 (de) 2002-06-12
IL141328A0 (en) 2002-03-10
SI1105386T1 (en) 2002-12-31
US6686379B2 (en) 2004-02-03
KR20010072487A (ko) 2001-07-31
CN1318065A (zh) 2001-10-17
PL345993A1 (en) 2002-01-14
UA58605C2 (uk) 2003-08-15
ATE219074T1 (de) 2002-06-15
NO319782B1 (no) 2005-09-12
EP1105386A1 (de) 2001-06-13
DE69901840T2 (de) 2003-05-22
NZ509761A (en) 2003-08-29
BG65255B1 (bg) 2007-10-31
EA004431B1 (ru) 2004-04-29
DE122005000049I1 (de) 2006-12-28
NO20010718D0 (no) 2001-02-12
HUP0103257A3 (en) 2003-01-28
EE200100054A (et) 2002-06-17
SK2362001A3 (en) 2001-09-11
PT1105386E (pt) 2002-11-29
HRP20010117A2 (en) 2002-02-28
AU761715B2 (en) 2003-06-05
US6410569B1 (en) 2002-06-25
BR9914288A (pt) 2001-06-19
CZ2001621A3 (cs) 2001-08-15
AU5515699A (en) 2000-03-14
CA2341031A1 (en) 2000-03-02
ES2178896T3 (es) 2003-01-01
IL141157A0 (en) 2002-02-10
HK1037616A1 (en) 2002-02-15
YU11301A (sh) 2003-12-31
IL141157A (en) 2007-06-17
ZA200100934B (en) 2002-03-04
HUP0103257A2 (hu) 2002-02-28
ME00562B (me) 2011-12-20
DE19843413C1 (de) 2000-03-30
PL198801B1 (pl) 2008-07-31
KR100657835B1 (ko) 2006-12-15
CN1146558C (zh) 2004-04-21
HU226618B1 (en) 2009-04-28
EA200100208A1 (ru) 2001-08-27
SK285105B6 (sk) 2006-06-01
WO2000010995A1 (en) 2000-03-02
DK1105386T3 (da) 2002-09-30
MXPA01001758A (es) 2002-04-17
CA2341031C (en) 2006-04-04
US20020188008A1 (en) 2002-12-12

Similar Documents

Publication Publication Date Title
ATE219074T1 (de) Neue salzform von pantoprazol
TR200000782T2 (tr) Resorsinol türevleri.
DE69941116D1 (de) G von gdf-8
DE60039296D1 (de) System zur bestimmung der endgültigen position von zähnen
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60114634D1 (de) Neue zusammensetzungen von minoxidil
ID29021A (id) Komposisi galantamina pelepasan terkontrol
ATE236899T1 (de) Neue kristallinische form des kaliumsalzes des (s)-omeprazols
DK1083903T3 (da) Brobundne indenopyrrolocarbazoler
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69907146T2 (de) Direkte oxidation von cycloalkanen
BR9907304B1 (pt) refratÁrio de alumina-magnÉsia-grafita.
DE60008353D1 (de) Hemihydrat von 16.alpha.-bromoepiandrosterone
TR199903132A3 (tr) Metalosan bilesiklerinin aktive edici kompozisyonu.
SE9801494D0 (sv) Novel use
ATE176668T1 (de) Neue 9-n-bicyclische nucleosidverbindungen nützlich als selektive inhibitoren von proinflammatorische cytokinen
DE50003452D1 (de) Wässrige zusammensetzung zur filzfreiausrüstung von wolle
DE60007360T2 (de) Amorphe modifikation von torasemid
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
DE50207869D1 (de) Metallorganisches antitumormittel
DE60103501D1 (de) Trennung von den produkten der polyamidammonolyse
TR199902605T2 (xx) Fibrinojenin azalt�lma y�ntemleri.
BR0110800A (pt) Polipeptìdeos antiangiogênicos
EP1483396A4 (de) Wit 3.0, neues gen zur kontrolle der wundheilung von weichgeweben
DK1131273T3 (da) 1,4-Diaryl-2-fluor-1-buten-3-olforbindelser og deres anvendelse til fremstilling af 1,4-diaryl-2-fluor-1,3-butadien- og 1,4-diaryl-2-fluor-2-butenforbindelser